Showing 1846 to 1860 of 2527 results


Overcoming resistance to Beta-lactam antibiotics in Bacterial species
Patents for licensing Consejo Superior de Investigaciones Científicas

LIGHTWEIGHT NEUTRON DOSIMETER
Patents for licensing Universitat Politècnica de Catalunya - UPC

Waste Treatment & Industrial Valorization
Research Services and Capabilities FUNDITEC

Innovative Technology to Utilize and Recycle Sewage Sludge
Innovative Products and Technologies Laser Consult Ltd.

New compound to successfully treat degenerative diseases of the retina
Patents for licensing Universidad de Alicante

Improvement of power quality in electrical smart grids
Innovative Products and Technologies University of Luxembourg

Smartroad Tools - non-destructive sub-road/sub-rail inspection
Patents for licensing Heurika Geographics

Connector for timber walls (X-shaped steel plate connector with curved extremities)
Patents for licensing Unismart - University of Padua Foundation![In vitro method for detecting tumor growth and diagnosing or prognosticating the risk of metastasis in a human subject that has be[…]](https://static8.innoget.com/uploads//2db5331b60422d5d9eb1fc1c6584193c3db79682.png)

In vitro method for detecting tumor growth and diagnosing or prognosticating the risk of metastasis in a human subject that has be[…]
Patents for licensing Fundación Instituto de Investigación Sanitaria de Santiago de Compostela (FIDIS)

Dispensing system for flexible packaging
Innovative Products and Technologies impulse

A device for electromechanical stimulation of 2D monolayer and 3D stem cell’s cultures for tissue engineering applications
Patents for licensing Universitat Politècnica de Catalunya - UPC

Stand-alone system for the purification of brackish water directly powered by photovoltaic solar energy
Patents for licensing UNIVERSIDAD DE ALICANTE

Novel derivatives of psammaplin A, a method for their synthesis and their use for the prevention or treatment of cancer
Patents for licensing CINBIO

Treating Cancer and Collagen-Associated Diseases by Using Anti-LOXL-2 Antibody
Patents for licensing Yeda

